<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01894503</url>
  </required_header>
  <id_info>
    <org_study_id>P500-0513</org_study_id>
    <nct_id>NCT01894503</nct_id>
  </id_info>
  <brief_title>Safety and Performance of the Steroid-Releasing S8 Sinus Implant</brief_title>
  <acronym>S8PK</acronym>
  <official_title>A Clinical Evaluation of the Safety and Performance of the Steroid-Releasing S8 Sinus Implant When Used in Post-Sinus Surgery Patients With Recurrent Sinus Polyps</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intersect ENT</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intersect ENT</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and performance of the steroid-releasing S8
      Sinus Implant when used in post sinus surgery patients who present with recurrent sinus
      obstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The S8 PK study is an open label trial conducted at one clinical center in 5 adults with
      chronic sinusitis, who had prior endoscopic sinus surgery but experience nasal
      obstruction/congestion symptoms and bilateral ethmoid polyposis. The S8 PK study assessed the
      safety, implant delivery to the ethmoid sinus and systemic exposure to mometasone furoate by
      measuring plasma mometasone furoate and cortisol concentrations through 30 days
      post-procedure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Bilateral in-office placement of the S8 Sinus Implant (mometasone furoate, 1350 mcg) in the ethmoid sinuses</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Successful deployment on implant into the ethmoid sinus</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Chronic Sinusitis</condition>
  <arm_group>
    <arm_group_label>S8 Sinus Implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bilateral in-office placement of the S8 Sinus Implant (mometasone furoate sinus implant, 1350 mcg) in the ethmoid sinuses</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S8 Sinus Implant (mometasone furoate, 1350 mcg)</intervention_name>
    <description>Bioabsorbable sinus implant with 1350 mcg of mometasone furoate released over 90 days</description>
    <arm_group_label>S8 Sinus Implant</arm_group_label>
    <other_name>Mometasone furoate sinus implant, 1350 mcg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of chronic sinusitis

          -  Prior sinus surgery with ethmoidectomy

          -  Recurrent sinus obstruction due to polyps

        Exclusion Criteria:

          -  Required use of mometasone furoate

          -  Significant scarring of the sinus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randall Ow, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sacramento ENT</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sacramento ENT</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2013</study_first_submitted>
  <study_first_submitted_qc>July 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2013</study_first_posted>
  <disposition_first_submitted>March 19, 2015</disposition_first_submitted>
  <disposition_first_submitted_qc>March 19, 2015</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">April 8, 2015</disposition_first_posted>
  <last_update_submitted>March 13, 2017</last_update_submitted>
  <last_update_submitted_qc>March 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mometasone Furoate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan</ipd_description>
  </patient_data>
  <pending_results>
    <submitted>April 10, 2018</submitted>
    <returned>May 10, 2018</returned>
    <submitted>May 23, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

